{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q9BVP2",
      "entity_text" : "NS",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ02052",
      "entity_text" : "IMN",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "This case and data from literature support the idea that RTX could be used as a first-line therapy for patients at risk of progression because of persistent NS caused by IMN.",
  "reading_complete" : "2020-07-28T16:34:43Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T16:31:16Z",
  "trigger" : "caused",
  "evidence" : [ "NS caused by IMN" ],
  "pmc_id" : "6024028",
  "score" : 0
}